Skip to main content

Table 1 General characteristics of subjects

From: Metabolic syndrome biomarkers and early breast cancer in Saudi women: evidence for the presence of a systemic stress response and/or a pre-existing metabolic syndrome-related neoplasia risk?

 

Control

Breast cancer

P value

N

53

56

 

Age (years)

43.1 ± 7.5

46.4 ± 11.3

0.10

Age at Menarche (years)

13.1 ± 1.0

12.9 ± 1.6

0.48

Age at 1st Pregnancy (years)

21.0 ± 3.8

19.6 ± 4.3

0.19

Menopause (%)

9 (17)

22 (40)

0.01

Body Mass Index (kg/m2)

31.0 ± 5.4

31.4 ± 7.7

0.81

Systolic BP (mmHg)

112.3 ± 11.98

118.6 ± 15.5

0.03

Diastolic BP (mmHg)

73.3 ± 7.0

70.9 ± 10.5

0.22

SAD (cm)

22.1 ± 5.8

20.2 ± 8.3

0.30

Waist circumference (cm)

88.8 ± 18.8

96.3 ± 22.2

0.08

Hip circumference (cm)

106.5 ± 21.4

105.5 ± 18.2

0.81

Glucose (mmol/l)

5.4 ± 0.63

5.9 ± 1.2

0.01

Triglycerides (mmol/l)

1.3 ± 0.22

1.9 ± 0.38

0.001

Total Cholesterol (mmol/l)

4.7 ± 0.62

4.9 ± 1.0

0.27

LDL-Cholesterol (mmol/l)

3.6 ± 0.76

3.7 ± 1.0

0.51

HDL-Cholesterol (mmol/l)

0.86 ± 0.29

0.72 ± 0.26

0.01

C-Reactive Protein (ug/ml)

4.4 ± 0.11

7.5 ± 0.21

0.04

ANG II (ng/ml)

0.77 ± 0.15

0.99 ± 0.29

0.02

Leptin (ng/ml)

16.0 ± 2.2

25.6 ± 1.7

0.044

Adiponectin (ug/ml)

19.1 ± 1.2

14.8 ± 1.0

0.02

TNF-α (pg/ml)

4.6 ± 0.57

6.0 ± 0.75

0.045

aPAI (ng/ml)

14.6 ± 1.3

12.2 ± 2.8

0.08

Resistin (ng/ml)

15.2 ± 1.0

18.9 ± 1.2

0.04

Ca (mmol/l)

2.4 ± 0.23

2.3 ± 0.58

0.18

Pi (mmol/l)

1.2 ± 0.18

1.6 ± 0.34

<0.001

  1. Note: Data presented as mean ± SD; P-value significant at < 0.05.